Ospedale San Luca IRCCS Istituto Auxologico Italiano
Milan, 20149, Italy
Location status: Recruiting
NCT Number: NCT06309550
Diagnosing heart failure with preserved ejection fraction (HFpEF) in patients complaining exertional breathlessness can be challenging: diagnostic algorithms and scores have low sensitivity, and ageing-associated comorbidities can complicate the interpretation of symptoms. Thus, exercise right heart catheterization (RHC) or invasive cardiopulmonary exercise test (iCPET) have been advocated as gold-standard methods for HFpEF diagnosis. However, exercise RHC and iCPET are still not widely standardized methods, with results mainly coming from US cohorts (that may differ from Italian cohorts), and other provocative tests (e.g. non-invasive CPET, passive leg raising) may offer complementary diagnostic information.
Interested in participating?
Request InfoAll sexes
Observational
Milan, 20149, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
exercise test
Time frame: 5 years
Incidence of mortality
Time frame: 5 years
Incidence of hospitalization for heart failure
Time frame: 5 years
Incidence of atrial fibrillation
Contact information is provided by the study sponsor or research team.
Istituto Auxologico Italiano
Other
Provocative Tests for Diagnosing and Phenotyping Heart Failure With Preserved Ejection Fraction
Acronym: TEST-PEF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081543
Cardiovascular Diseases, Heart Diseases
Columbus, Ohio, United States
View Trial DetailsNCT07202000
Heart Failure With Preserved Ejection Fraction
Boston, Massachusetts, United States
View Trial DetailsNCT07083011
Heart Failure With Preserved Ejection Fraction
Rochester, Minnesota, United States
View Trial DetailsNCT07214376
Cardiovascular Diseases, Heart Diseases
Houma, Louisiana, United States
View Trial Details